Homocysteine and short-term risk of myocardial infarction and stroke in the elderly: the Rotterdam Study.
about
Homocysteine, folate and vitamin B12 in neuropsychiatric diseases: review and treatment recommendationsHomocysteine and ischaemic stroke in men: the Caerphilly studyHomocysteine and coronary heart disease in the Caerphilly cohort: a 10 year follow upHomocysteine levels in chronic gastritis and other conditions: relations to incident cardiovascular disease and dementiaAssociations between plasma homocysteine levels, aortic stiffness and wave reflection in patients with arterial hypertension, isolated office hypertension and normotensive controlsPlasma homocysteine, dietary B vitamins, betaine, and choline and risk of peripheral artery disease.Preventive health care, 2000 update: screening and management of hyperhomocysteinemia for the prevention of coronary artery disease events. The Canadian Task Force on Preventive Health Care.Effect of enalapril on plasma homocysteine levels in patients with essential hypertension.Homocysteine, silent brain infarcts, and white matter lesions: The Rotterdam Scan Study.Homocysteine, vitamins, and coronary artery disease. Comprehensive review of the literatureAssociation between B vitamins supplementation and risk of cardiovascular outcomes: a cumulative meta-analysis of randomized controlled trials.Total homocysteine is associated with white matter hyperintensity volume: the Northern Manhattan Study.Folic Acid Supplementation and the Risk of Cardiovascular Diseases: A Meta-Analysis of Randomized Controlled TrialsHomocyst(e)ine and cardiovascular disease: a systematic review of the evidence with special emphasis on case-control studies and nested case-control studies.Herbal, vitamin, and mineral supplement use in patients enrolled in a cardiac rehabilitation program.Endothelial dysfunction and atherothrombosis in mild hyperhomocysteinemia.Homocysteine and carotid plaque stability: a cross-sectional study in Chinese adults.The renin-angiotensin-aldosterone system and Alzheimer s disease?DACH-LIGA homocystein (german, austrian and swiss homocysteine society): consensus paper on the rational clinical use of homocysteine, folic acid and B-vitamins in cardiovascular and thrombotic diseases: guidelines and recommendations.Relationship between increase of serum homocysteine caused by smoking and oxidative damage in elderly patients with cardiovascular disease.Preventing a second stroke in the young.Greater intake of vitamins B6 and B12 spares gray matter in healthy elderly: a voxel-based morphometry study.Prevalence of hyperhomocysteinemia in healthy Indian doctors.Therapeutical approach to plasma homocysteine and cardiovascular risk reduction.Homocysteine and cardiovascular disease: a review of the evidence.Use of Framingham risk score and new biomarkers to predict cardiovascular mortality in older people: population based observational cohort study.Stroke: roles of B vitamins, homocysteine and antioxidants.The Protective Effects of Icariin against the Homocysteine-Induced Neurotoxicity in the Primary Embryonic Cultures of Rat Cortical Neurons.Novel biomarkers with potential for cardiovascular risk reclassification.Meta-analysis study to evaluate the association of MTHFR C677T polymorphism with risk of ischemic stroke.Hyperhomocysteinemia as an Early Predictor of Erectile Dysfunction: International Index of Erectile Function (IIEF) and Penile Doppler Ultrasound Correlation With Plasma Levels of Homocysteine.Helicobacter pylori masks differences in homocysteine plasma levels between controls and type 2 diabetic patients.Homocysteine in neuropsychiatric disorders of the elderly.Total plasma homocysteine, age, systolic blood pressure, and cognitive performance in older people.Homocysteine and coronary heart disease: the importance of a distinction between low and high risk subjects.Where are we standing in homocysteine research?[Homocysteine and neuropsychiatric disorders].Diet, serum homocysteine levels and ischaemic heart disease in a Mediterranean population.Atherosclerosis and folic acid supplementation trial in chronic renal failure: baseline results.Association of serum total homocysteine with the extent of ischemic heart disease in a Mediterranean cohort.
P2860
Q28259237-F36668B4-D474-4C51-A1B4-7AFA9DDF0AE3Q28345707-1044A739-83A0-419B-B3AB-723298DAC659Q28345971-2B34DEA5-261A-45FC-8F8D-CDDBA6FEB33DQ33583592-8BDB3B2A-222B-4E35-8AF7-72C170DD6848Q33753246-9CF7356D-7165-4FB8-B156-A9388058215DQ33915599-0B098909-DC3F-40A0-823E-5C96297B8B68Q34038098-43BFF3B3-1A01-4677-B780-54F2D43CBB17Q34044262-9E0DBF3F-6F61-4A48-A5C5-7CAAEE2C2329Q34118216-86C3705A-E2EC-497F-970D-28D992F09776Q34121446-E9C23138-C8AF-4E83-917F-2DF3FBC6944DQ34215572-1AD9B835-5041-40D1-B92D-D5FB8F30F852Q34316338-927C620F-EFEE-4779-85B6-FE2AB936D1DBQ34537420-5E3B9B53-C8D3-4C4D-9782-16BACDCEDC34Q34577250-D2F87D22-4BAB-4EC6-BD80-BFE6E803B39FQ35050124-86D73882-1986-400F-BA5B-97FF4EF806C0Q35055199-978455DF-6314-43B0-B977-E91DC559D748Q35149310-A88CF466-C4EF-4ABE-9DF3-D4C7826E66E9Q35154546-3B65CA24-FF08-4F13-9480-995D63455091Q35600410-5DE87E4F-DE64-4151-999F-7DD5A137D204Q35644123-1AD35955-22B7-4961-ABC0-C9AA72013201Q35760828-A624D36A-6860-4F2C-9A04-E61217CBBB54Q36570089-828DD0F3-02B0-4499-A33D-33728A53D97AQ36700510-90275C10-0228-4683-B0C7-6CE7A4D9F134Q36822904-81D420D0-C3A0-4A0D-A067-7094F24F3CDCQ36892501-CF6DA469-4045-4415-A1F0-19D031C5FF8FQ37041666-AE6F000E-3CBE-4EAF-8085-A38B86212CC4Q37531010-5B1DADDC-3B0F-4C25-A706-F41E4D541739Q38791608-B7CBDBF7-DDA5-4AC8-B780-5D7AB394CC78Q38864815-BD08F71D-C70E-4768-807F-0F37D877A2FFQ41031164-802E9AE7-C334-483F-B3D8-EEE6D34EAE02Q42039893-E81A45BA-E1F3-48E4-AECC-1AED413B1614Q43918432-0123B693-F8B6-4CEF-A429-06511045FD0DQ44131619-9779740E-F6EC-4F70-8F5A-7A622CD445F4Q44242957-9B83623B-530D-475B-836F-C44FC8C4F84EQ44286470-CCF4682B-DE9D-46C7-81F4-165DD0B61E95Q44679981-F6FB8DD6-8C41-4815-A119-C99CFD596588Q44825250-80B5DD5F-7D90-46BD-8A3D-9AEEA7D042A6Q44925406-E3906271-4302-420F-8B7E-52F5267187FDQ44930530-50F2F9B2-8F05-4DDD-98B3-5A02190EE484Q45065894-43F1F523-FD78-4FCC-9E43-B84D5D3451C1
P2860
Homocysteine and short-term risk of myocardial infarction and stroke in the elderly: the Rotterdam Study.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
1999年學術文章
@zh-hant
name
Homocysteine and short-term ri ...... elderly: the Rotterdam Study.
@en
Homocysteine and short-term ri ...... elderly: the Rotterdam Study.
@nl
type
label
Homocysteine and short-term ri ...... elderly: the Rotterdam Study.
@en
Homocysteine and short-term ri ...... elderly: the Rotterdam Study.
@nl
prefLabel
Homocysteine and short-term ri ...... elderly: the Rotterdam Study.
@en
Homocysteine and short-term ri ...... elderly: the Rotterdam Study.
@nl
P2093
P1476
Homocysteine and short-term ri ...... elderly: the Rotterdam Study.
@en
P2093
Grobbee DE
Koudstaal PJ
Lindemans J
Witteman JC
P356
10.1001/ARCHINTE.159.1.38
P407
P577
1999-01-01T00:00:00Z